Pharmacokinetics of 8-O-Acetylharpagide in Mouse Blood by UPLC-MS/MS

• Published in: Acta chromatographica Vol. 31; no. 3; p. 183
• Main Authors: Chen, Shanjiang, Huang, Miaoling, Yu, Zheng, He, Jiamin, Huang, Binge, Wang, Xianqin, Ma, Jianshe, Wen, Congcong
• Format: Journal Article
• Language: English
• Published: Budapest Akademiai Kiado 01.09.2019; Akademiai Kiado Zrt
• Subjects: Acetonitrile; Analysis; Anticancer properties; Bioavailability; Blood; Chromatography; Elution; Ethylene; Flow velocity; Formic acid; Inflammation; Intravenous administration; Ionization; Ions; Linearity; Liquid chromatography; Mass spectrometry; Mass spectroscopy; Methanol; Nitriles; Oral administration; Organic acids; Pharmacokinetics; Pharmacology; Scientific imaging; Selectivity; Spectroscopy; Tumors; Viruses
• ISSN: 1233-2356; 2083-5736
• DOI: 10.1556/1326.2018.00429

8-O-Acetylharpagide is the main active component of the herb Ajuga decumbens, which possesses anti-tumor, antivirus, and anti-inflammation properties. In this study, ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to measure the concentration of 8-O-acetylharpagide in mouse blood, with subsequent investigation of the pharmacokinetics of the drug after intravenous or oral administration. Shanzhiside methyl ester was used as an internal standard, and the acetonitrile precipitation method was used to process the blood samples. Chromatographic separation was achieved using an ultra-performance liquid chromatography ethylene-bridged hybrid (UPLC BEH) column (2.1 mm X 50 mm, 1.7 [micro]m) with a gradient methanol-water mobile phase (containing 0.1% formic acid). The flow rate was 0.4 mL/min, and the elution time was 5.0 min. 8-O-Acetylharpagide was quantitatively measured using electrospray ionization (ESI) tandem mass spectrometry in multiple reaction monitoring (MRM) mode with positive ionization. The result indicated that, within the range of 5-500 ng/mL, the linearity of 8-O-acetylharpagide in mouse blood was satisfactory (r > 0.995), and the lower limit of quantification (LLOQ) was 5 ng/mL. Intra-day precision relative standard deviation (RSD) of 8-O-acetylharpagide in blood was lower than 9%, and the inter-day precision RSD was lower than 13%. The accuracy range was between 94.3% and 107.1%, average recovery was higher than 91.3%, and the matrix effect was between 100.8% and 110.8%. This analytical method was sensitive and fast with good selectivity and was successfully applied to perform pharmacokinetic studies of 8-O-acetylharpagide in mice. The bioavailability of 8-O-acetylharpagide was 10.8%, and the analysis of the primary pharmacokinetic parameters after oral and intravenous administration indicated that 8-O-acetylharpagide had a significant first pass effect after oral administration. Keywords: 8-O-acetylharpagide, pharmacokinetics, bioavailability, mouse, UPLC-MS/MS